Discovery of a brain-permeable bromodomain and extra terminal domain (BET) inhibitor with selectivity for BD1 for the treatment of multiple sclerosis
Xuetao Chen, Tingting Wu, Zhiyan Du, Wenjing Kang, Rujun Xu, Fanying Meng, Chihong Liu, Yali Chen, Qichao Bao, Jingkang Shen, Qidong You, Danyan Cao, Zhengyu Jiang, Xiaoke Guo
Topics & Concepts
ChemistryBromodomainExperimental autoimmune encephalomyelitisNeuroinflammationPharmacologyMicrogliaBiophysicsMultiple sclerosisBiochemistryImmunologyMedicineInflammationBiologyGeneAcetylationProtein Degradation and InhibitorsMultiple Myeloma Research and TreatmentsRNA Interference and Gene Delivery